Dr. Raveen Syan, MD

Dr. Syan practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Syan's NPI, 1194086918, was assigned on June 7, 2012. Dr. Syan graduated from Keck School of Medicine of USC in 2012. Dr. Syan holds Florida license ME140822.

Dr. Syan's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Syan's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Syan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Syan practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Syan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Syan is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Syan's licenses on file in 2 states: Florida and California.

Dmand AI lists bladder disease, enlarged prostate, kidney cysts, kidney stone disease, pelvic prolapse, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Syan treats.

CMS data shows 1,477 Medicare services from Dr. Syan across 18 procedure codes in 2024, for 300 Medicare patients. Medicare paid $131,667 for them.

CMS counts 300 Medicare patients who saw Dr. Syan in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Syan's median patient age at 68, with 75% women.

In 2024, Dr. Syan wrote 950 Medicare Part D claims for 261 patients. 76% of them were for generic drugs. CMS names the drug for 838 of them, across 16 drugs with 11 or more claims each, at $156,228 in total drug cost. In 2023, CMS named 604 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Syan for performance year 2024, reported as part of a group. Dr. Syan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Syan as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Syan, published from 2015 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Pelvic Organ Prolapse, Urinary Bladder, Overactive and Urinary Incontinence, Stress. Dr. Syan has published most often in Urology. Dr. Syan's most frequent co-authors are Ekene Ada Enemchukwu, MD, Katherine A. Amin, MD and Benjamin M. Brucker, MD.

CMS Open Payments shows 103 general payments to Dr. Syan from 20 drug and device companies from 2017 to 2025. Education make up the largest share, 60% of the total. Intuitive Surgical, Inc. paid the most, $12,000.

Dr. Syan graduated from Keck School of Medicine of USC in 2012.

Dr. Syan is in network with 12 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.